ERBB2 and breast carcinoma: We suggest that the S1P pathway could be an important therapeutic avenue to overcome the resistance to drug therapies, such as hormonal therapy, anti-HER2 therapy, or chemotherapy, all of which are crucial aspects of breast cancer treatment.